Rallybio Corporation

RLYB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$32,122$9,445$14,779$13,903
Short-Term Investments$27,197$36,304$39,716$51,608
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,308$4,516$2,886$2,330
Total Curr. Assets$66,627$50,265$57,381$67,841
Property Plant & Equip (Net)$224$112$189$267
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$626$413$0
Tax Assets$0$0$0$0
Other NC Assets$810$0$0$0
Total NC Assets$1,034$738$602$267
Other Assets$0$0$0$0
Total Assets$67,661$51,003$57,983$68,108
Liabilities
Payables$269$119$400$278
Short-Term Debt$90$58$116$154
Tax Payable$0$0$0$0
Deferred Revenue$424$636$848$848
Other Curr. Liab.$3,736$4,226$2,546$4,962
Total Curr. Liab.$4,519$5,039$3,910$6,242
LT Debt$108$0$0$0
Deferred Rev, NC$0$0$0$212
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$108$0$0$212
Other Liabilities$0$0$0$0
Cap. Leases$0$58$116$154
Total Liabilities$4,627$5,039$3,910$6,454
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$4$4
Retained Earnings-$296,146-$312,162-$302,459-$293,020
AOCI$0$17$47$68
Other Equity$359,176$358,105$356,481$354,602
Total Equity$63,034$45,964$54,073$61,654
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$67,661$51,003$57,983$68,108
Net Debt-$31,924-$9,387-$14,663-$13,749